Current promising treatment strategy for glioblastoma multiform: A review
Glioblastoma multiform (GBM) is a heterogeneous group of primary neoplasm resistant to conventional therapies. Due to their infiltrative nature it not fully isolated by aggressive surgery, radiation and chemotherapy showing poor prognosis in glioma patients. Unfortunately, diagnosed patients die wit...
Main Authors: | Sanjib Bahadur, Arvind Kumar Sahu, Pragya Baghel, Suman Saha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://www.oncologyreviews.org/index.php/or/article/view/417 |
Similar Items
-
Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality
by: Chooi Yeng Lee, et al.
Published: (2016-09-01) -
Hypofractionated Radiation Therapy with Temozolomide for Patients with Glioblastoma Multiforme Recursive Partitioning Analyzes Class V and VI
by: Fuzuli Tuğrul, et al.
Published: (2019-09-01) -
The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
by: Łukasz A. Poniatowski, et al.
Published: (2024-01-01) -
Medical image of the month: glioblastoma multiforme
by: Roose CA, et al.
Published: (2020-09-01) -
Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management
by: Brandon Edelbach, et al.
Published: (2024-03-01)